Ocular rosacea is a chronic inflammatory condition that affects the eyelids and the surface of the eyes. While many people associate rosacea with facial redness, flushing, or visible blood vessels on the cheeks and nose, the same inflammatory process can also involve the eyes—often years before skin symptoms become noticeable. One of the earliest signs of ocular rosacea is the development of tiny, enlarged blood vessels along the eyelid margin, known as telangiectasia. These abnormal vessels release inflammatory chemicals that interfere with the normal function of the meibomian glands, the oil-producing glands responsible for keeping your tears from evaporating too quickly. As inflammation progresses, the quality of the tear film begins to decline. Tears become unstable, the surface of the eye dries out, and patients may experience burning, redness, watery eyes, fluctuating vision, light sensitivity, and persistent irritation. Left untreated, chronic inflammation can lead to permanent damage to the meibomian glands, making dry eye disease more difficult to treat over time. At FLOW, we look beyond temporary symptom relief to identify the underlying source of inflammation. Through advanced ocular surface evaluation, we assess eyelid health, tear film stability, and meibomian gland function to determine whether ocular rosacea is contributing to your symptoms. Treatment is designed to calm inflammation and restore healthy gland function. Depending on your condition, this may include Intense Pulsed Light (IPL) therapy, radiofrequency treatment, thermal gland expression, medical eyelid hygiene, and a personalized long-term management plan to help restore comfort and protect your vision. When inflammation is treated at its source, patients often experience healthier eyes, clearer vision, and lasting relief from chronic dry eye symptoms.